Seeing Is Believing
SURF is currently covered by 3 analysts with an average potential upside of $6.75 (184.08%) from yesterday's end of day stock price of $1.07. Surface Oncology activity chart has currently 1 price targets and 5 ratings on display.
Analysts average stock forecasts to be materialized ratio is 23.33% with an average time for these price targets to be met of 89.67 days.
Highest price target for SURF is $1, Lowest price target is $1, average price target is $1.
Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 20-Jun-2023. First documented stock forecast 28-Aug-2020.
Currently, out of the existing stock ratings of SURF - 3 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
3
5 months 19 days ago
1/5 (20%)
$7.15 (162.91%)
140
Buy
5
$3.93 (367.29%)
11
5 months 19 days ago
1/2 (50%)
$4.55 (288.38%)
129
Buy
17
1 years 1 months 6 days ago
0/1 (0%)
$8.54 (100.95%)
What is SURF (Surface Oncology) average time for price targets to be met?
Which analyst has the current highest performing score on SURF (Surface Oncology) with a proven track record?
Which analyst has the current lower performing score on SURF (Surface Oncology) with a proven track record?
Which analyst has the most public recommendations on SURF (Surface Oncology)?
Which analyst is the currently most bullish on SURF (Surface Oncology)?
Which analyst is the currently most reserved on SURF (Surface Oncology)?